Home |
|
EDUCATION PROGRAM
|
CONTENTS
E1. Hematomorphology
E2. Stem Cell Transplantation
E3. Update on Hypercoagulability
E4. Cytogenetics
E5. Recent Advances in Apheresis
E6. Thalassemia and Hemoglobinopathy
E7. Malignant Lymphoma
E8. Update on Bleeding Disorders
E9. Histocompatibility in Field of Hematology
E10. Understanding and Treatment of Acquired Aplastic Anemia
E11. The Biology and Treatment of Acute Myeloid Leukemia
E12. Chronic Leukemia
E13. Myelodysplastic Syndrome
E14. Safety Issues in Blood & Blood Products Transfusion
E15. Non-malignant Hematologic Disorders in Childhood
E16. Treatment of Childhood Malignancy
E17. Role of Blood and Marrow Nurses in Field of Transplants
E18. Current Concepts of the Myeloproliferative Diseases
E1. Hematomorphology
E1-1. The Diagnosis from the Pathological Viewpoint of a Blood Disease
Ito Masafumi (Japan)
E1-2. The Role of Morphology, Cytochemistry and Immunohistochemistry in the Diagnosis of Chronic Myeloproliferative Diseases
Li Chin-Yang (USA)
E1-3. The Role of Morphology, Cytochemistry and Immunohistochemistry in the Diagnosis of Lymphoproliferative Disorders
Chi Hyun-Sook (Korea)
E1-4. Plasmacytic Lesions of the Bone Marrow
Hyun Bong Hak (Korea)
Contents
E2. Stem Cell Transplantation
E2-1. Mini-Transplantation Strategy for Solid Tumors
Takaue Yoichi (Japan)
E2-2. Chronic Graft-versus-host Disease and Late Effects after Hematopoietic Stem Cell Transplantation
Sanders Jean E. (USA)
E2-3. Allogeneic Hemopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndrome or Myelofibrosis
Deeg H. Joachim, Guardiola Philippe (USA)
Contents
E3. Update on HyperCoagulability
E3-1. Targeted Gene Disruption of Natural Anticoagulant Proteins in Mice
Kojima Tetsuhito (Japan)
E3-2. Treatment of Venous Thromboembolism
Ageno Walter (Italy)
E3-3. Effects of Hormone Replacement Therapy on Coagulation and Fibrinolysis in Postmenopausal Women
Koh Kwang Kon (Korea)
E3-4. Recent Advances in the Diagnosis of Antiphospholipid Syndrome
Chi Hyun-Sook (Korea)
Contents
E4. Cytogenetics
E4-1. Monitoring the Course of Chronic Myelogenous Leukemia by Fluorescence In Situ Hybridization
Seong Chu-Myong (Korea)
E4-2. Genetics of Childhood Acute Lymphoblastic Leukemia
Pui Ching-Hon (USA)
E4-3. Integrating Cytogenetics and Gene Expression Profiling in the Molecular Analysis of Multiple Myeloma
Shaughnessy John D. and Barlogie Bart (USA)
E4-4. Cytogenetic and FISH Studies in Myelodysplasia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia and Lymphoma
Dewald Gordon (USA)
Contents
E5. Recent Advances in Apheresis
E5-1. Pediatric Apheresis: Special Emphasis on Peripheral Blood Progenitor Cell Harvest in Children
Kim Haewon C. (USA)
E5-2. Granulocyte Transfusion in the G-CSF Era
Price Thomas H. (USA)
E5-3. The Eight-year Experience of Plasmapheresis in Patients with Neurological Diseases
Chiu Hou-Chang, Yeh Jiann-Horng, Chen Wei-Hung (Taiwan)
Contents
E6. Thalassemia and Hemoglobinopathy
E6-1. Thalassemia and Abnormal Hemoglobin
Fucharoen Suthat, Winichagoon Pranee (Thailand)
E6-2. Thalassemia Mutations and Their Clinical Aspects in Japan
Hattori Yukio (Japan)
E6-3. Beta-Thalassemia in the Korean Population
Park Sung Sup, Cho Han-Ik (Korea)
E6-4. Beta-Thalassaemia Prototype of a Single Gene Disorder with Multiple Phenotypes
Thein Swee Lay (UK)
E6-5. Carrier Screening and Genetic Counselling in Beta-Thalassemia
Cao Antonio (Italy)
Contents
E7. Malignant Lymphoma
E7-1. High Dose Chemotherapy and Autologous Transplantation for Non-Hodgkin's Lymphoma
Vose Julie M. (USA)
E7-2. PTCL: Lessons from Adult T-cell Leukemia
Matsuoka Masao (Japan)
E7-3. NK Cell Lymphoma
Oshimi Kazuo (Japan)*826
Contents
E8. Update on Bleeding Disorders
E8-1. Idiopathic Thrombocytopenic Purpura: Pathophysiology and Management
Ahn Yeon S. and Horstman Lawrence L (USA)
E8-2. Deficiency of ADAMTS13 in Thrombotic Thrombocytopenic Purpura
Tsai Han-Mou (USA)
E8-3. Management of Bleeding Disorders by Prohemostatic Therapy
Levi Marcel, Vink Roel, Jonge Evert de (Netherlands)
E8-4. Molecular Diagnosis of von Willebrand Disease
Ruan Changgeng (China)
Contents
E9. Histocompatibility in Field of Hematology
E9-1. Current and Emerging Technology for HLA Typing
Middleton D. (Ireland)
E9-2. HLA Diversity: Detection and Impact on Unrelated Hematopoietic Stem Cell Donor Characterization and Selection
Hurley Carolyn Katovich (USA)
E9-3. Minor Histocompatibility Antigens Targets of Graft versus Leukemia Responses
Riddell S.R., Murata M., Bryant S., Warren E.H. (USA)
Contents
E10. Understanding and Treatment of Acquired Aplastic Anemia
E10-1. Views on the Pathophysiology of Aplastic Anaemia
Gordon-Smith E.C., Marsh J.C., and Gibson F.M. (UK)
E10-2. New Advances in the Treatment of Acquired Severe Aplastic Anaemia
Hows Jill (UK)
E10-3. The Relationship of Aplastic Anemia and PNH
Young Neal S., Maciejewski Jaroslaw P., Sloand Elaine, Chen Guiben, Zeng Weihua, Risitano Antonio, and Miyazato Akira (USA)
E10-4. Aplastic Anemia in the Orient
Kojima Seiji (Japan)
Contents
E11. The Biology and Treatment of Acute Myeloid Leukemia
E11-1. Clinical Importance of Genetic Findings in Adult AML
Bloomfield Clara D. (USA)
E11-2. Biologically Risk Directed Therapy for Improved Trial Development and Outcomes in Patients with AML
Arceci Robert J. (USA)
E11-4. New Advances in the Treatment of Acute Promyelocytic Leukemia
Douer Dan (USA)
Contents
E12. Chronic Leukemia
E12-1. Treatment of Chronic Myeloid Leukaemia Lessons and Challenges
Goldman John (UK)
E12-2. Clinical and Scientific Advances in the Philadelphia-Chromosome Negative Chronic Myeloproliferative Disorders
Mesa Ruben A. (USA)
E12-3. Real-time PCR for Monitoring Minimal Residual Disease and Chimerism in Patients after Allogeneic Transplantation
Elmaagacli Ahmet H. (Germany)
E12-4. Biology and Modulation of Multidrug Resistance (MDR) in Hematological Malignancies
Hirose Masao (Japan)
Contents
E13. Myelodysplastic Syndrome
E13-1. Molecular Pathogenesis of MDS
Hirai Hisamaru (Japan)
E13-2. Important Features of Myelodysplastic Syndrome
Hofmann Wolf-K., Koeffler H. Phillip (USA)
E13-3. The Myelodysplastic Syndromes: Morphology, Risk Assessment, and Clinical Management (2002)
Bennett John M., Kouides Peter A., Forman Stephen J. (USA)
Contents
E14. Safety Issues in Blood & Blood Products Transfusion
E14-1. Human T Lymphotropic Virus Type-I and Adult T-Cell Leukemia in Japan
Yamaguchi Kazunari, Watanabe Toshiki (Japan)
E14-2. Human Herpesvirus 6 and Human Herpesvirus 7: Emerging Pathogens in Transplant Patients
Clark Duncan A. (UK)
E14-4. Pathogen Inactivation of Blood Components: Current Status and Introduction of an Approach Using Riboflavin as a Photosensitizer
Corbin Frank III (USA)
E14-5. The Quest for Quality Blood Banking Program in the New Millennium the American Way
Kim Dae Un (USA)
Contents
E15. Non-malignant Hematologic Disorders in Childhood
E15-1. Childhood ITP
Kim Haewon C. (USA)
E15-2. An Approach to the Diagnosis and Treatment of Bleeding Disorders in Infants
Abshire Thomas (USA)
E15-3. Non-myeloablative Hematopoietic Cell Transplant for Treatment of Nonmalignant Disorders in Children
Woolfrey Ann, Pulsipher Michael A., Storb Rainer (USA)
Contents
E16. Treatment of Childhood Malignancy
E16-1. Current Concepts in Treatment of Childhood Acute Lymphoblastic Leukemia
Pui Ching-Hon (USA)
E16-2. Childhood Acute Lymphoblastic Leukemia: Differences in Drug Resistance between Sub-groups of ALL
Veerman A.J.P. (Netherlands)
E16-3. Designer Drugs: New Directed Therapies for Cancer
Feig Stephen A. (USA)
E16-4. Umbilical Cord Blood for Unrelated Bone Marrow Replacement; Asia Bank and Japan Cord Blood Bank Network Update
Mugishima Hideo, Takahashi Tuneo, Nagamura Tokiko, Asano Sigetaka, Saito Hidehiko (Japan)
Contents
E17. Role of Blood and Marrow Nurses in Field of Transplants
E17-1. Role of the Advanced Practice Nurse in Blood and Marrow Transplantation
Neumann Joyce L. (USA)
E17-2. Research within the Field of Blood and Marrow Transplantation Nursing: How Can It Contribute to Higher Quality of Care?
Fliedner Monica C. (Switzerland)
E17-3. The Present State of Advanced Practice Nursing in Hematopoietic Stem Cell Transplantation Field in Korea
Hong Jung Hee (Korea)
Contents
E18. Current Concepts of the Myeloproliferative Diseases
E18-1. Treatment of Polycythemia Vera with Recombinant Interferon
Silver Richard T. (USA)
E18-2. The Therapy of Myelofibrosis: Targeting Pathogenesis
Mesa Ruben A. (USA)
E18-3. Basic Sciences of the Myeloproliferative Diseases: Pathogenic Mechanisms of ET and PV
Gale Rosemary E. (UK)
E18-4. What is the Standard Treatment in Essential Thrombocythemia
Barbui Tiziano (Italy)
Contents